Journal article
Low dose, low cost estradiol pellets can support MCF-7 tumour growth in nude mice without bladder symptoms
G Dall, J Vieusseux, A Unsworth, R Anderson, K Britt
Journal of Cancer | IVYSPRING INT PUBL | Published : 2015
DOI: 10.7150/jca.10890
Open access
Abstract
MCF-7 cells are a slow growing estrogen receptor (ER) positive human breast cancer cell line that is commonly used to model estrogen responsive breast cancer cell growth in-vitro and tumour growth in-vivo. These tumours require estrogen supplementation, and in-vivo doses of between 0.72mg and 2mg estradiol pellets are commonly implanted in the dorsal flank of ovariectomised, immunocompromised mice. We wanted to grow MCF-7 tumours in immunocompromised mice without the need to be ovariectomised. When we treated immunocompromised mice with 0.72mg pellets to induce MCF7 tumour growth, the mice developed urosepsis. We have now shown that lower doses of estradiol pellets, 0.3mg and 0.5mg, induce e..
View full abstractGrants
Funding Acknowledgements
We thank the animal facility at Peter MacCallum Cancer Centre for their assistance. GD and AU are supported by Australian Postgraduate Scholarships, RA was supported by National Breast Cancer Foundation of Australia Fellowship. KB was supported by a National Breast Cancer Foundation of Australia Fellowship, a VCA early career seeds grant and an NHMRC new investigator grant.